Altre lingue Applied Therapeutics, Inc.

Azioni

APLT

US03828A1016

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 19/04/2024			Variaz. 5gg	Var. 1 gen.
4,38 ^USD	-7,59%		-13,44%	+30,75%

15/04	Applied Therapeutics, Inc. annuncia cambiamenti nella dirigenza	CI
28/03	Applied Therapeutics ottiene un'estensione del periodo di revisione della NDA per il trattamento della galattosemia -- Azioni in calo dopo le ore.	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer	15/04
Applied Therapeutics, Inc. Announces Management Changes	15/04
Applied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024	04/04
Applied Therapeutics Shares Slip 13% After FDA Extends Drug Review	28/03
FDA Extends Review Period for Applied Therapeutics Genetic Disease Treatment	28/03
Applied Therapeutics Gets NDA Review Period Extension for Galactosemia Treatment -- Shares Fall After Hours	28/03
US FDA extends review of Applied Therapeutics' genetic disease drug	28/03
Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia	28/03
Applied Therapeutics, Inc. Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia	28/03
Applied Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	06/03
Earnings Flash (APLT) APPLIED THERAPEUTICS Reports Q4 Revenue $10M	06/03
Applied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial Results	06/03
Applied Therapeutics, Inc. announced that it has received $99.997998 million in funding from a group of investors	01/03
Applied Therapeutics' NDA for Govorestat Accepted by FDA; Launches $100 Million Private Placement; Shares Jump	28/02
Applied Therapeutics Shares Surge on FDA Review, $100 Million Funding Round	28/02
Applied Therapeutics Announces $100 Million Private Placement	28/02
Applied Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for Govorestat for the Treatment of Classic Galactosemia	28/02
Applied Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for Govorestat for the Treatment of Classic Galactosemia	28/02
Sector Update: Health Care Stocks Higher Late Afternoon	16/02
Sector Update: Health Care	16/02

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Applied Therapeutics, Inc.

Azioni

APLT

US03828A1016

Altre lingue

Filtri